Johns Hopkins Univ Company Profile
✉ Email this page to a colleague
What is the competitive landscape for JOHNS HOPKINS UNIV, and what generic and branded alternatives to JOHNS HOPKINS UNIV drugs are available?
JOHNS HOPKINS UNIV has one approved drug.
Summary for Johns Hopkins Univ
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 1 |
Drugs and US Patents for Johns Hopkins Univ
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Johns Hopkins Univ | AMMONIA N 13 | ammonia n-13 | INJECTABLE;INTRAVENOUS | 204514-001 | Aug 19, 2014 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
